DNA Script to Present at 40th Annual J.P. Morgan Healthcare Conference

SOUTH SAN FRANCISCO, Calif., and PARIS | January 5, 2022

Company to Webcast Presentation Monday, January 10, 2022, at 2 p.m. EST

DNA Script, a leader in Enzymatic DNA Synthesis (EDS) for on-demand DNA printing, today announced that its CEO and co-founder Thomas Ybert, Ph.D., will present on the Company’s growth and vision at the 40th Annual J.P. Morgan Healthcare Conference, being held virtually. Ybert’s session will take place on Monday, January 10, 2022, at 11:00 a.m. PST / 2:00 p.m. EST.

Registered attendees may access sessions at the following link during the conference: https://jpmorgan.metameetings.net/events/healthcare22.